PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 18, 2026ACS Nano3 citations

Optimization of Lipid Nanoparticles for Safe and Versatile Lung-Targeted RNA Delivery and Disease Therapy

View Full Paper
YFYuan FeiYLYi LinPLPeiyu Liu

Key Points

  • The aim is to optimize lipid nanoparticles for effective and safe RNA delivery to the lungs.
  • Developed and characterized lipid-392 stLNP for RNA delivery.
  • Assessed safety and efficiency of the platform in preclinical models.
  • Lipid-392 stLNP demonstrated a safe RNA delivery profile at approximately 0.05 mg/kg.
  • The platform showed effectiveness for lung-targeted therapy across various diseases.

Abstract

) of approximately 0.05 mg/kg. Taken together, these findings establish Lipid-392 stLNP as a safe, efficient, and versatile platform for lung-targeted RNA delivery with broad therapeutic potential for various diseases and promising translational applications.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Fei et al. (2026) studied this question.

synapsesocial.com/papers/6a0aabf55ba8ef6d83b6f924https://doi.org/10.1021/acsnano.6c03013
Ask AI
Helpful
Bookmark
Share
View Full Paper